BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.370
-0.100 (-6.80%)
At close: Dec 5, 2025, 4:00 PM EST
1.361
-0.009 (-0.66%)
After-hours: Dec 5, 2025, 4:35 PM EST
BioCardia Employees
As of December 31, 2024, BioCardia had 20 total employees, including 16 full-time and 4 part-time employees. The number of employees did not change compared to the previous year.
Employees
20
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$427,000
Market Cap
14.54M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCDA News
- 4 days ago - BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress - GlobeNewsWire
- 12 days ago - BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality - GlobeNewsWire
- 23 days ago - BioCardia, Inc. (BCDA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results - GlobeNewsWire
- 4 weeks ago - BioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025 - GlobeNewsWire
- 2 months ago - BioCardia Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 2 months ago - BioCardia Announces Pricing of Up To $12 Million Public Offering - GlobeNewsWire
- 2 months ago - BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-up - GlobeNewsWire